This inventor holds 1 USPTO granted patent. Top assignee: Amneal Pharmaceuticals LLC. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Maheta Abhay Subodhbhai: Innovator in Pharmaceutical Chemistry
Introduction
Maheta Abhay Subodhbhai is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug preparation. His work has implications for the production of important medications, showcasing his expertise and innovation in the industry.
Latest Patents
Maheta holds a patent for a process for the preparation of saxagliptin and its hydrochloride salt. This patent describes an improved and industrially feasible method for synthesizing saxagliptin, a medication used to treat type 2 diabetes. The patent also details novel intermediates and their applications in the preparation of saxagliptin or its hydrochloride salt, highlighting the inventive steps taken to enhance the production process.
Career Highlights
Maheta Abhay Subodhbhai is currently associated with Amneal Pharmaceuticals LLC, a company known for its commitment to developing high-quality generic and specialty pharmaceuticals. His role at Amneal allows him to apply his innovative ideas in a practical setting, contributing to the advancement of pharmaceutical manufacturing.
Collaborations
He has collaborated with notable coworkers, including Butani Pankaj Changanbhai and Patil Shashikant Prabhakarrao. These collaborations have likely fostered a creative environment that encourages the exchange of ideas and expertise in pharmaceutical development.
Conclusion
Maheta Abhay Subodhbhai's contributions to pharmaceutical chemistry, particularly through his patent for saxagliptin, demonstrate his innovative spirit and commitment to improving drug preparation processes. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
